Epidemiological Update: Occurrence of variants of SARS-CoV-2 in the Americas (20 January 2021)
Actualización Epidemiológica: ocurrencia de variantes de SARS-CoV-2 en las Américas (20 de enero del 2021)
Date
2021-01-20Metadata
Show full item recordOther Language Versions
Abstract
The appearance of mutations is a natural and expected event within the evolution of the virus. Since the initial genomic characterization of SARS-CoV-2, the virus has been divided into different genetic groups or clades. In fact, some specific mutations define the viral genetic groups (also called lineages) that are currently circulating globally. La aparición de mutaciones es un evento natural y esperado dentro del proceso de evolución de los virus. Desde la caracterización genómica inicial del SARS-CoV-2, este virus se ha dividido en diferentes grupos genéticos o clados. De hecho, algunas mutaciones específicas definen los grupos genéticos virales (también denominados linajes) que circulan actualmente a nivel global.
Subject
Collections
Related items
Showing items related by title, author, creator and subject.
-
Regional Update, Influenza. Epidemiological Week 41 (26 October 2021)
(Washington, D.C., PAHO, 2021-10-26)[WEEKLY SUMMARY]. North America: Overall, influenza activity remained low. In Canada and Mexico respiratory syncytial virus (RSV) detections continued to increase and in the United States, RSV activity continues to decrease. ... -
Regional Update, Influenza and Other Respiratory Viruses. Epidemiological Week 6 (17 February 2023)
(Washington, D.C., PAHO, 2023-02-23)[WEEKLY SUMMARY]. North America: Influenza activity was low overall in the subregion. Influenza A(H1N1)pdm09 continued predominating with the co-circulation of A(H3N2) and B/Victoria. The SARS-CoV-2 and RSV activity ... -
Regional Update, Influenza and Other Respiratory Viruses. Epidemiological Week 8 (3 March 2023)
(Washington, D.C., PAHO, 2023-03-09)[WEEKLY SUMMARY]. North America: Influenza activity was low in the subregion. Influenza A(H3N2)pdm09 predominated, with the co-circulation of A(H1N1)pdm09 and B/Victoria. SARS-CoV-2 circulates at moderate levels and RSV ...
